Is the pharma industry ready to listen directly to patients?
January 5, 2021

COO Elizabeth Fairley was recently interviewed by publisher Drug Discovery World on whether the pharmaceutical industry is ready to listen directly to patients?

Elizabeth commented that “There has been a growing realisation that pharmaceutical companies must change if they are going to enable and harness technology even more successfully.

There has been a recognition that digital expertise must be brought in and that there must be digital working alongside robust science. In the scientific world it’s all about measurement and it’s the same in the digital world. Bringing the two together is what really accelerates it.

By bringing in the patient into the journey a lot sooner than just in the clinical stage of drug discovery, huge advances can continue to be made. There’s a slight reservation about actually talking to the patient. The apprehension is understandable as there are huge barriers to be overcome from a regulatory and compliance standpoint.

It’s curious but the voice of the people taking the drugs – the actual patients – hasn’t been as loud as it should have been. That’s despite extensive evidence that listening to patients and learning about their experiences can dramatically improve drug development, delivery, and accessibility, as well as patient support.

What we’re finding first hand is that the technology can identify barriers to access and opportunities for growth, and provide enhanced support for optimized health outcomes. We’re now able to assemble information about patient experiences with existing drugs which wouldn’t have been possible without technology.

In the work we’re doing, we can now gather patient voices from a number of different sources and cleanse and structure the information in a meaningful way. Conversational data can be derived from social media sites and forums where people discuss their experiences with diseases and medicines. This can be blended with information with data gathered directly from people using our connected devices as well as through patient surveys.

With data blended from so many different sources, we’re now starting to hear new things that are valuable to the industry. By getting close to people and learning in detail about the experiences they are having with the medicines they are taking we can be of assistance to patients with regard to managing their diseases. And we’re able to act as a translator, interpreting between the different language spoken by patients and medics, an approach which assists in diagnostics as well as disease management.

it is important that patients are listened to, especially as they are being brought in to more of the decision process across diagnosis and the management of their conditions and treatment. It is vital that the patient is kept safe to drive the better health outcomes.”

The full article in DDW is here.

 

Recent Blogs

Pfizer and BioNTech gain approval on new COVID-19 vaccine

Pfizer and BioNTech gain approval on new COVID-19 vaccine

This long-awaited moment has finally arrived! This morning, Pfizer and BioNTech’s vaccine has been approved for use in the UK as early as next week. It is the fastest vaccine ever to be developed, taking only 10 months to convert the concept into reality, a process...

Protecting Your Medical Data with Elizabeth Fairley and Ellie Halliday

Protecting Your Medical Data with Elizabeth Fairley and Ellie Halliday

DIGIT spoke with Elizabeth Fairley and Ellie Halliday of Talking Medicines about keeping your medical data safe in a Covid world. Medical data is among the most sensitive information a company can gather, store or track, and the coronavirus pandemic has heightened...

COVID-19 Vaccine: A fresh start

COVID-19 Vaccine: A fresh start

There is no doubt that 2020 has been a long, hard year. With the endless threat of new measures and long lockdowns, it is safe to say we could do with some good news. Finally, we have a glimmer of hope. First, Pfizer (Pharmaceutical company) announced the interim...

Talking Medicines identified as top AI Company

Talking Medicines identified as top AI Company

Data tech innovator Talking Medicines, which uses advanced AI to provide pharmaceutical companies with real-time data intelligence, has been chosen to join Tech Nation’s Applied AI 2.0 Growth Programme. Tech Nation’s growth programmes are designed to champion and...